184 related articles for article (PubMed ID: 28805579)
21. External Capsular Hyperintensities in Wilson's Disease Presenting with Refractory Status Epilepticus.
Ruchika T; Madhukar M; Abhishek KG
Neurol India; 2022; 70(6):2446-2448. PubMed ID: 36537433
[TBL] [Abstract][Full Text] [Related]
22. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
23. A Rare Neuropsychiatric Presentation of Adult-Onset Wilson's Disease.
Muneer A
J Coll Physicians Surg Pak; 2016 Nov; 26(11):148-150. PubMed ID: 28666514
[TBL] [Abstract][Full Text] [Related]
24. Psychiatric and behavioral abnormalities in Wilson's disease.
Akil M; Brewer GJ
Adv Neurol; 1995; 65():171-8. PubMed ID: 7872138
[TBL] [Abstract][Full Text] [Related]
25. Subclinical neurological involvement does not develop if Wilson's disease is treated early.
Dubbioso R; Ranucci G; Esposito M; Di Dato F; Topa A; Quarantelli M; Matarazzo M; Santoro L; Manganelli F; Iorio R
Parkinsonism Relat Disord; 2016 Mar; 24():15-9. PubMed ID: 26851839
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of oxidative events and copper accumulatıon in oral tissues of patients wıth Wilson's disease: three case report.
Ozturk M; Karacelebi E; Gungor K; Coskun S; Boysan E
Int J Clin Exp Pathol; 2015; 8(4):3943-5. PubMed ID: 26097579
[TBL] [Abstract][Full Text] [Related]
27. Wilson's disease with depression and parkinsonism.
Chan KH; Cheung RT; Au-Yeung KM; Mak W; Cheng TS; Ho SL
J Clin Neurosci; 2005 Apr; 12(3):303-5. PubMed ID: 15851088
[TBL] [Abstract][Full Text] [Related]
28. Copper deposition in oligodendroglial cells in an autopsied case of hepatolenticular degeneration.
Nishimuta M; Masui K; Yamamoto T; Ikarashi Y; Tokushige K; Hashimoto E; Nagashima Y; Shibata N
Neuropathology; 2018 Jun; 38(3):321-328. PubMed ID: 29468756
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and features of non-motor symptoms in Wilson's disease.
Palmieri GR; De Michele G; Matarazzo M; Di Dato F; Perillo S; Dello Iacovo DCP; Cuomo N; Pane C; Russo CV; Iorio R; De Michele G; De Rosa A
Parkinsonism Relat Disord; 2022 Feb; 95():103-106. PubMed ID: 35093711
[TBL] [Abstract][Full Text] [Related]
30. Cerebral manifestation of Wilson's disease successfully treated with liver transplantation.
Bax RT; Hässler A; Luck W; Hefter H; Krägeloh-Mann I; Neuhaus P; Emmrich P
Neurology; 1998 Sep; 51(3):863-5. PubMed ID: 9748041
[TBL] [Abstract][Full Text] [Related]
31. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
Prasad R; Kaur G; Walia BN
Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
[TBL] [Abstract][Full Text] [Related]
32. [Wilson's disease].
Brůha R; Marecek Z; Martásek P; Nevsímalová S; Petrtýl J; Urbánek P; Kalistová H; Pospísilová L
Cas Lek Cesk; 2009; 148(11):544-8. PubMed ID: 20662462
[TBL] [Abstract][Full Text] [Related]
33. Wilson's disease.
Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of chronic Wilson's disease in 2 patients using plasmapheresis--clinico-biochemical observations].
Milovanović DD; Tomasević R; Bogdanović G
Srp Arh Celok Lek; 1998; 126(9-10):327-34. PubMed ID: 9863403
[TBL] [Abstract][Full Text] [Related]
35. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
[TBL] [Abstract][Full Text] [Related]
36. Acute Gallbladder Hydrops and Arthritis: unusual initial manifestations of Wilson's Disease (WD): Case Report.
Gucev ZS; Pop-Jordanova N; Calovska V; Tasic V; Slavevska N; Laban N; Noli MC; Lepori MB; Loudianos G
Prilozi; 2011; 32(2):307-15. PubMed ID: 22286624
[TBL] [Abstract][Full Text] [Related]
37. Cognitive profile in Wilson's disease: a case series of 31 patients.
Wenisch E; De Tassigny A; Trocello JM; Beretti J; Girardot-Tinant N; Woimant F
Rev Neurol (Paris); 2013 Dec; 169(12):944-9. PubMed ID: 24120329
[TBL] [Abstract][Full Text] [Related]
38. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
Dzieżyc K; Karliński M; Litwin T; Członkowska A
Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
[TBL] [Abstract][Full Text] [Related]
39. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease.
LaRusso NF; Summerskill WH; McCall JT
Gastroenterology; 1976 May; 70(5 PT.1):653-5. PubMed ID: 1261757
[TBL] [Abstract][Full Text] [Related]
40. Transient elastography of the liver in children with Wilson's disease: Preliminary results.
Stefanescu AC; Pop TL; Stefanescu H; Miu N
J Clin Ultrasound; 2016 Feb; 44(2):65-71. PubMed ID: 26177868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
